4XP-12012-70842
4 vaccinations
3 coded responses
39 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 454 / OH
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Dose 1 — Moderna
-
2021-02-18
Registered in v-safe
- 2021-02-18
-
2021-02-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-03-02
- 2021-03-09
-
2021-03-16
Dose 2 — Moderna
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-22
- 2021-04-27
- 2021-06-15
-
2021-09-14
Survey response — 6 months, dose 2MedDRA: Adverse drug reaction, Trigeminal neuralgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Adverse reaction to new medication related to trigeminal neuralgia. Medication caused below range for sodium, chloride, and other electrolytes. Experienced nausea, weakness, jittery, fell once, etc. Weaned off medication and working my way back.MedDRA releases: 2024-11 · check-in free text available
-
2021-09-14
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-09-16
-
2021-11-11
Dose 3 — Moderna
- 2022-03-19
-
2022-05-23
Dose 4 — Moderna
- 2022-05-23
-
2022-05-24
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-05-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-05-26
- 2022-05-27
- 2022-05-28
- 2022-05-29
- 2022-05-30
- 2022-06-06
- 2022-06-13
- 2022-06-20
-
2022-06-27
Survey response — day 35, dose 4MedDRA: Fatigue, Headache, Malaise, Medical counselling, Respiratory tract congestion — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Head and chest congestion, fatigue, headache, feeling lousy. · Healthcare visit (other): Call to doc. for antiviral meds.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Report sent to call center — day 35, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2022-06-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-07-04
Survey response — day 42, dose 4MedDRA: Adverse drug reaction, Asthenia, Dizziness, Fall, Fatigue, Feeling abnormal, Headache, Pulmonary congestion, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Positive COVID Test 6/27. Congested lungs/head, fatigue, fuzzy thinking, headache,, weakness. Reaction to Plaxclovid light headed, nearly fell twice, sat on floor. NP stopped after 2doses.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-04
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-05
Call successfulParticipant prefers to complete VAERS report online
- 2022-08-22
- 2022-11-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Moderna | |
| 2 | 2021-03-16 | Moderna | |
| 3 | 2021-11-11 | Moderna | No |
| 4 | 2022-05-23 | Moderna | No |
Call center
3 call center cases
3 successful
Free text
Release 9 — 6 months, dose 2
Symptoms: Adverse reaction to new medication related to trigeminal neuralgia. Medication caused below range for sodium, chloride, and other electrolytes. Experienced nausea, weakness, jittery, fell once, etc. Weaned off medication and working my way back.
Release 12 — day 35, dose 4
Symptoms: Head and chest congestion, fatigue, headache, feeling lousy.
Healthcare visit (other): Call to doc. for antiviral meds.
Release 12 — day 42, dose 4
Symptoms: Positive COVID Test 6/27. Congested lungs/head, fatigue, fuzzy thinking, headache,, weakness. Reaction to Plaxclovid light headed, nearly fell twice, sat on floor. NP stopped after 2doses.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Adverse drug reaction | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fall | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling abnormal | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pulmonary congestion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Trigeminal neuralgia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release